Assoc Director, Health Systems Medical Outcomes Science Liaison (Southeast)

Alnylam Pharmaceuticals

9d•$187,700 - $253,900•Remote

About The Position

The Health System Medical Outcomes Science Liaison (HS MOSL) is a field-based scientific expert who serves as Alnylam's primary medical liaison within integrated delivery networks (IDNs), academic health systems, and organized healthcare entities. The HS MOSL engages formulary decision makers, C-suite healthcare leaders, clinical pharmacists, and broader clinical leaders who influence formulary and access decisions - providing balanced, evidence-based scientific and health economic information that supports informed formulary, access, and clinical pathway decisions while identifying collaborative research opportunities that advance evidence generation. Territory includes: FL, NC, SC, KY, TN, GA

Requirements

Advanced degree - MD, DO, PharmD, or PhD in a relevant life science discipline.
5+ years of Medical Affairs experience in pharmaceutical or biotech; prior field-based experience working directly with health systems or IDNs strongly preferred.
Demonstrated understanding of pharmacoeconomic and health outcomes research principles.
Solid working knowledge of US healthcare ecosystems, IDN structure, and formulary decision-making processes.
Strong therapeutic area knowledge; rare disease experience preferred.
Solid working knowledge of regulatory and compliance environment including PhRMA, OIG, and FDA guidelines.
Excellent written and verbal communication skills; ability to engage diverse audiences from clinical staff to C-suite system leaders.
Ability to travel up to 75%; must reside within assigned territory.
Valid driver's license required.

Nice To Haves

HEOR fellowship, MS, MBA, or MPH is a plus.
Experience with federal health systems (VA, DoD) is a plus.

Responsibilities

Engage and build peer-level relationships with formulary decision makers, C-suite healthcare leaders, clinical pharmacists, pharmacy directors, and key clinical leaders who influence formulary decisions within IDNs and health systems.
Conduct balanced, evidence-based scientific exchange to address data needs, gather insights, and communicate the clinical and economic value of Alnylam's portfolio.
In collaboration with the Health System Director (HSD), develop account-specific strategic plans including a detailed assessment of key influencers and decision makers.
Collect and share evidence gaps and insights to inform Alnylam's Value, Evidence, and Strategy (VESt) Team and advance meaningful data generation.
Engage health system stakeholders in evidence-based scientific and outcomes-focused dialogue, drawing on relevant clinical and health economic data to support awareness of diagnostic and treatment considerations across the disease area at the system level.
Identify scientific research collaboration opportunities including real-world evidence generation by leveraging internal stakeholders (Medical Affairs, Value & Access, VESt).
Provide HEOR and outcomes data to support formulary review processes, clinical pathway development, and health system value assessments.
Support regional and national IDN/healthcare systems congresses as needed.
Collaborate closely with MSL colleagues to ensure integrated territory-level scientific strategy across clinical and system-level stakeholders.
Maintain a thorough understanding of compliance requirements and applicable PhRMA Codes, OIG guidelines, FDA laws, and Alnylam's policies.
Apply business acumen to prioritize health system engagements that maximize scientific impact and access for patients.
Independently and proactively applies strategic thinking, scientific expertise, engagement excellence, integrity-driven conduct, and cross-functional collaboration within the health system driving strong execution and continuous improvement across access stakeholder engagement.